nondiabetic

Related by string. nondiabetics * * nondiabetic patients . nondiabetic subjects *

Related by context. All words. (Click for frequent words.) 72 normotensive 71 CC genotype 71 nonobese 70 nondiabetic patients 70 MetS 69 fasting insulin 69 elevated triglyceride levels 68 highest tertile 68 aged ≥ 68 fasting glucose levels 67 adiponectin concentrations 67 nondepressed 67 fasting triglyceride levels 67 confidence interval #.#-#.# 67 cognitively normal 67 hydroxyvitamin D levels 67 lowest tertile 67 diabetes mellitus DM 66 T1DM 66 serum lipid levels 66 advanced adenoma 66 T2DM 66 serum selenium 66 elevated triglycerides 66 glycated hemoglobin levels 66 advanced neoplasia 66 plasma adiponectin 66 Baseline characteristics 66 euthyroid 66 systolic blood pressures 65 TT genotype 65 ejection fractions 65 mIU L 65 HbA1C levels 65 serum IGF 65 alanine aminotransferase ALT 65 advanced adenomas 65 MMSE scores 65 troponin T 65 hypertensives 65 nondiabetics 65 waist circumferences 65 nonfasting triglyceride levels 65 hypercholesterolemic 65 #.#mmol L [002] 65 hip BMD 65 CARDIA 64 tertile 64 HIV uninfected 64 hsCRP levels 64 CVD mortality 64 triacylglycerol concentrations 64 subclinical hyperthyroidism 64 fetuin 64 autonomic dysfunction 64 heterozygotes 64 #mmHg [001] 64 systolic dysfunction 64 elevated LDL cholesterol 64 elevated fasting glucose 64 severe periodontitis 64 albumin excretion 64 impaired glucose tolerance 64 subclinical hypothyroidism 64 thyrotropin levels 64 Hb A1C 64 NHANES III 64 colorectal neoplasia 64 colorectal adenoma 64 Hb A1c 64 dysglycemia 64 serum concentrations 64 BMI z 64 mineral density 63 gallstone disease 63 amnestic MCI 63 multivariable adjusted 63 osteopenic 63 APOE e4 63 μmol L 63 rs# [001] 63 elevated LDL 63 elevated hsCRP 63 GH deficiency 63 poor metabolizers 63 coronary calcification 63 plasma folate 63 allele frequencies 63 umol L 63 serum uric acid 63 dietary calcium intake 63 telomere lengths 63 alanine aminotransferase 63 infarcts 63 diastolic hypertension 63 undergone radical prostatectomy 63 pg ml 63 atherogenic dyslipidemia 63 HbA1c levels 63 HIV HCV coinfected 63 homozygotes 63 HbA 1c 63 IDDM 63 genotyped 63 highest quintile 63 pg mL 63 hemoglobin A1c levels 63 ABCB1 63 BRCA1 mutation carriers 63 nmol L 63 CrCl 63 CHD mortality 63 cirrhotic 62 triglyceride concentrations 62 undergoing radical prostatectomy 62 serum urate levels 62 urinary albumin 62 shorter telomere length 62 serum leptin 62 Complication rates 62 proband 62 hyperinsulinemic 62 T2D 62 isolated systolic hypertension 62 femoral neck BMD 62 recurrent acute pancreatitis 62 habitual snoring 62 elevated ALT 62 aortic atherosclerosis 62 HOMA IR 62 Insulin sensitivity 62 mmol l 62 HNSCC 62 fasting glucose 62 rs# [004] 62 % CI #.#-#.# [003] 62 nondemented 62 rs# [003] 62 serum creatinine levels 62 retrospective cohort 62 kg m² 62 underwent radical prostatectomy 62 prostate cancer CaP 62 mmHg diastolic 62 intact parathyroid hormone 62 polycystic ovary syndrome PCOS 62 amnestic mild cognitive impairment 62 elevated uric acid 62 carotid IMT 62 Framingham Offspring Study 62 SHBG levels 62 fasting plasma 62 endometrial thickness 62 glucose intolerant 62 glycemia 62 thyroid hormone levels 62 onset diabetes mellitus 62 NAFLD 62 impaired fasting glucose 62 abnormal lipid 62 HbA 1c levels 62 % CI #.#-#.# [006] 61 obese postmenopausal 61 HDL cholesterol triglycerides 61 mm Hg diastolic 61 coinfected 61 #mg/dL [001] 61 arterial thickening 61 % CI #.#-#.# [007] 61 tertiles 61 ELBW infants 61 underwent bariatric surgery 61 BMI ≥ 61 mm Hg systolic 61 dietary intakes 61 dapagliflozin plus 61 adenoma 61 NNRTI resistance 61 impaired glucose metabolism 61 prevalences 61 cardiorespiratory fitness 61 cardiovascular mortality 61 mL/min/#.# m 2 61 colorectal carcinoma 61 HMGA1 61 blood glucose concentrations 61 carotid plaque 61 serum triglyceride 61 BCG vaccinated 61 hemoglobin A1c HbA1c 61 hypogonadal 61 obstructive coronary artery 61 IPAH 61 total cholesterol triglycerides 61 CRP concentrations 61 P = .# 61 gene polymorphism 61 GSTT1 61 HIV seronegative 61 ADPKD 61 carotid plaques 61 pre eclamptic 61 lispro 61 serum phosphate 61 hippocampal volumes 61 preeclamptic 61 serum triglycerides 61 carotid stenosis 61 nmol l 61 plasma triglycerides 61 baseline serum creatinine 61 atherosclerotic lesions 61 underwent CABG 61 nonischemic 61 μg L 61 premenopausal 61 macroalbuminuria 61 Multivariate analyzes 61 colorectal cancer incidence 61 lymphocytosis 61 CHD CVD 61 subclinical atherosclerosis 61 nonvertebral fractures 61 microbleeds 61 oral antidiabetic medication 61 diastolic BP 61 % CI #.#-#.# [008] 61 atypical hyperplasia 61 SGPT 61 CP CPPS 61 #.#ng/ml 61 diastolic function 61 rs# [002] 61 carotid artery intima media 60 kg/m2 60 folate vitamin B 60 ng dL 60 serum folate 60 EpCAM expression 60 sporadic ALS 60 basal cell nevus syndrome 60 mmHg systolic 60 serum estradiol 60 elevated CRP 60 transferrin saturation 60 BRCA1 mutations 60 albumin excretion rate 60 Serum calcium 60 atrophic gastritis 60 GSTM1 60 hydroxyvitamin D concentrations 60 microalbuminuria 60 serum testosterone 60 gestational diabetes mellitus 60 BMD measurements 60 nonpregnant women 60 thrombocytopenic 60 neutrophil counts 60 serum cholesterol 60 perimenopausal women 60 penetrance 60 abdominal obesity 60 antiretroviral naïve 60 adenomatous polyps 60 HCV infected 60 nulliparous women 60 APOE ε4 60 lipid levels 60 HbA1C 60 recurrent VTE 60 fasting blood glucose 60 leukocyte count 60 coronary artery calcification 60 intima media thickness 60 CI #.#-#.# [001] 60 serum PTH 60 estimated glomerular filtration 60 GBA mutations 60 lactate dehydrogenase 60 colorectal adenomas 60 hypertension diabetes mellitus 60 prehypertensive 60 biochemical recurrence 60 leptin concentrations 60 elevated serum creatinine 60 depressive symptomatology 60 LV dysfunction 60 de novo AML 60 diastolic blood pressures 60 shorter telomeres 60 metabolic abnormalities 60 APOE e4 gene 60 p = .# [002] 60 Fasting glucose 60 waist girth 60 cognitively intact 60 serum vitamin D 60 hyperlipidaemia 60 drank pomegranate juice 60 calcium intakes 60 plasma lipids 60 albuminuria 60 serum homocysteine 60 MELD scores 60 histologically confirmed 60 REYATAZ r arm 60 PCa 60 macrovascular disease 60 NAT2 60 hyperhomocysteinemia 60 glycosylated hemoglobin HbA1c 60 fasting serum 60 seronegative 60 baseline HbA1c 60 autoantibody positive 60 PaO 2 60 plasma leptin 60 serum insulin 60 serum calcium 60 preintervention 60 urate levels 60 prepubertal 60 RYGB surgery 60 #OHD levels 60 thyrotropin 59 noncarriers 59 nonpregnant 59 mU L 59 narcolepsy cataplexy 59 Asymptomatic 59 CARDIA study 59 Hp2 2 59 abdominal adiposity 59 fractional anisotropy 59 cancerous prostates removed 59 logistic regression analysis 59 PRADAXA #mg 59 overt hypothyroidism 59 pT3 59 glycosylated hemoglobin levels 59 white matter hyperintensities 59 flutamide 59 affective psychoses 59 erythrocyte sedimentation rate 59 folate concentrations 59 LDL cholesterol concentrations 59 cTnT 59 noncardiac 59 % CI #.#-#.# [002] 59 serum lipids 59 parous women 59 pCR 59 #q# deletion 59 urinary albumin excretion 59 male Sprague Dawley 59 pmol liter 59 diabetes mellitus hypertension 59 HER2 expression 59 asymptomatic PAD 59 BRCA2 mutations 59 BMPR2 59 choline intake 59 intracranial hemorrhage ICH 59 LDL particle 59 cagA 59 TEAEs 59 nonalcoholic steatohepatitis NASH 59 vitamin D intakes 59 nontraumatic 59 confidence interval CI 59 abdominal circumference 59 neurological abnormalities 59 PTPN# 59 lipid concentrations 59 ALT elevation 59 systolic hypertension 59 Median survival 59 hyperinsulinemia 59 N telopeptide 59 cerebral infarction 59 #mg/day [001] 59 rCBF 59 VLDL cholesterol 59 undetectable PSA 59 glucose tolerance 59 mild renal impairment 59 preoperative PSA 59 immunocompetent 59 creatinine ratio 59 fasting plasma glucose 59 IGFBP 59 stone formers 59 psychiatric comorbidities 59 colorectal neoplasms 59 hypophosphatemia 59 polyp recurrence 59 apolipoprotein B 59 MYH9 gene 59 urolithiasis 59 folate deficiency 59 hydroxyvitamin D 59 diabetes mellitus 59 Univariate analysis 59 cystatin C 59 Fasting plasma glucose 59 serum retinol 59 distal colon cancer 59 NYHA functional class 59 metabolically healthy 59 serum albumin 59 onset atrial fibrillation 59 pmol L 59 posttransplant 59 GH deficient 59 lymphocyte counts 59 basal bolus therapy 59 serum ALT 59 cryptogenic 59 latent celiac disease 59 non fasting triglycerides 59 #mmHg [002] 59 elevated serum ALT 59 nulliparous 59 left ventricular systolic 59 limiting generalizability 59 nonfasting 59 mIU ml 59 nonfasting triglycerides 59 kaempferol 59 glycated hemoglobin 59 nondiabetic subjects 59 PON1 activity 59 2D 4D ratio 59 confidence intervals CIs 59 C#Y 59 SE alleles 59 carotid artery thickness 59 ductal breast cancer 59 oral glucose tolerance 59 Fasting blood glucose 59 cortisol concentrations 59 % Confidence Interval 59 nonpsychotic 59 glycated hemoglobin HbA1c 59 valvular disease 59 β blockers 58 plasma creatinine 58 index BMI 58 elevated creatinine 58 dietary glycemic index 58 proliferative diabetic retinopathy 58 isoprostane 58 overt nephropathy 58 left ventricular hypertrophy 58 hypothalamic amenorrhea 58 tumor histology 58 Framingham Offspring 58 interleukin IL -6 58 serum calcium levels 58 serous ovarian cancer 58 nonalcoholic steatohepatitis 58 E selectin 58 elevated homocysteine 58 BMI percentile 58 intracranial atherosclerosis 58 mass indexes BMIs 58 Prehypertension 58 type2 diabetes 58 glycosylated hemoglobin 58 anthropometric measures 58 μg liter 58 aminotransferase levels 58 nonmetastatic 58 anemia hemoglobin 58 arterial oxygen saturation 58 comorbid illnesses 58 genetic variants associated 58 Leydig cell 58 parous 58 -#.# ± [001] 58 symptomatic intracerebral hemorrhage 58 iPTH 58 UGT#A# * 58 serum ferritin 58 familial pancreatic cancer 58 gestational hypertension 58 liver histology 58 chromosome #q#.# [001] 58 antiretroviral naive 58 serum BDNF 58 adiposity 58 atherothrombosis 58 DAS# scores 58 Apolipoprotein E 58 microvascular complications 58 LVEF 58 Breslow thickness 58 plasma homocysteine levels 58 Swedish Mammography Cohort 58 lactate dehydrogenase LDH 58 prostate carcinoma 58 thiazide diuretics 58 prospectively defined 58 CCR5 delta# 58 normal birthweight 58 PSA nadir 58 seropositivity 58 primary aldosteronism 58 bioavailable testosterone 58 postprandial insulin 58 mmol L 58 urine albumin 58 abnormal glucose tolerance 58 dyslipidaemia 58 hepatocellular carcinomas 58 hemoglobin concentrations 58 5 HTTLPR 58 cardioembolic stroke 58 C reactive protein 58 Serum concentrations 58 euthymic patients 58 lumbar spine bone 58 n = 58 cryptorchidism 58 variant alleles 58 inherited mutations 58 elevated depressive symptoms 58 variable ptau levels 58 central adiposity 58 affective psychosis 58 methylenetetrahydrofolate reductase 58 tHcy 58 obese adolescents 58 severe obstructive sleep 58 iron deficient 58 lacunar 58 isoenzyme 58 prospective cohort 58 histologic subtype 58 Hashimoto thyroiditis 58 familial hypercholesterolemia 58 sociodemographic characteristics 58 GSTP1 58 Wisconsin Sleep Cohort 58 renal cell carcinomas 58 paclitaxel eluting stents 58 hemodialysis patients 58 leptin deficiency 58 μg dl 58 proliferative retinopathy 58 metabolic syndrome 58 phylloquinone 58 probands 58 improves glycemic 58 μg dL 58 density lipoprotein cholesterol 58 NNT = 58 lipid profiles 58 nmol 58 triglyceride levels 58 NPH insulin 58 HDL2 58 VLBW 58 hematopoietic cancers 58 POAG 58 prolonged QT interval 58 URTI 58 osteosarcomas 58 heterozygous 58 sUA 58 PLX STROKE targeting 58 ventricular mass 58 tibiofemoral 58 haemorrhagic stroke 58 HLA DRB1 * 58 CDKN2A 58 cardio respiratory fitness 58 familial clustering 58 neurodevelopmental impairment 58 MACCE 58 Triglyceride levels 58 adiponectin levels 58 glomerular filtration 58 #q# deletion syndrome 58 stage IIIb IV 58 diastolic pressures 58 adjunctive ABILIFY 58 nmol L. 58 HGPIN 58 glulisine 58 HLA DR 58 visceral adiposity 58 cerebral oxygenation 58 aspartate aminotransferase AST 58 seminomas 58 triacylglycerol 58 diabetic rats 58 mild renal insufficiency 58 metabolic syndrome MetS 58 coronary artery calcium 58 HBeAg negative 58 patients undergoing CABG 58 microalbumin 58 x ULN 58 cholesterol LDL C 58 hyperlipidemic 58 overweight sedentary 58 liver transplant recipients 58 myocardial infarction MI 58 hypercholesterolemia 58 BMI waist circumference 58 abnormal lipid levels 58 serum potassium 58 Multivariate analysis 58 kidney allograft 58 LDL cholesterol HDL cholesterol 58 paricalcitol 57 hs CRP 57 oxygen desaturation 57 XIENCE V demonstrated 57 Aortic stenosis 57 lipid elevations 57 #mg/dL [002] 57 HER2 overexpression 57 baseline A1C 57 undergoing bariatric surgery 57 leukopenia 57 vertebral fracture 57 plasma homocysteine 57 SCN5A 57 -#.# ± [002] 57 HER2 positive cancers 57 hallux valgus 57 arterial stiffness 57 longitudinal cohort study 57 histological subtype 57 lumbar spine BMD 57 ob ob mice 57 specific antigen PSA 57 testicular germ cell 57 transaminase elevations 57 Young Adults CARDIA 57 p = ns 57 multivariate analyzes 57 Peripheral arterial disease 57 receiving ISENTRESS 57 LDL HDL 57 anovulatory infertility 57 nonvertebral fracture 57 atopic asthma 57 esophageal squamous cell carcinoma 57 serum PSA 57 waist circumference 57 gestational diabetes mellitus GDM 57 normal karyotype 57 INTERHEART 57 Vitamin D deficient 57 hemodynamically significant 57 Haptoglobin 57 intermittent exotropia 57 APOL1 57 serum parathyroid hormone 57 idiopathic PAH 57 MADRS score 57 gene APOE 57 born preterm 57 papillary renal cell carcinoma 57 CLA supplementation 57 juvenile idiopathic arthritis JIA 57 eosinophil count 57 hyperphenylalaninemia HPA due 57 diabetes dyslipidemia 57 HBeAg positive 57 perioperative complications 57 venous thrombosis 57 LQTS 57 multivariate adjustment 57 comorbid depression 57 NKX2 57 SNP rs# [002] 57 artery stenosis 57 fructose diet 57 HLA DR2 57 VADT 57 recurrent UTI 57 del 5q 57 carotid atherosclerosis 57 systolic diastolic 57 handgrip strength 57 preserved ejection fraction 57 loop diuretics 57 graft occlusion 57 HBeAg negative patients 57 inversely associated 57 serum GGT 57 Multivariate analysis showed 57 apnea hypopnea index 57 Subgroup analysis 57 sitosterol 57 hepatorenal syndrome 57 CK MB 57 metabolic parameters 57 ECG abnormalities 57 postmenopausal breast cancer 57 arterial thromboembolic events 57 relapsed MM 57 biochemical relapse 57 coinfection 57 pancreatic adenocarcinoma 57 myocardial infarctions 57 ovariectomized 57 neuritic 57 vascular dysfunction 57 CI #.#-#.# [002] 57 serum LDL cholesterol 57 hours postdose 57 metabolite concentrations 57 EoE 57 elevated lipase 57 K ras mutations 57 aspartate aminotransferase 57 affective disorders 57 leucopenia 57 hippocampal volume 57 inflammatory markers 57 CDH1 57 psychiatric morbidity 57 severe mitral regurgitation 57 improves insulin sensitivity 57 abdominally obese 57 ENPP1 57 definite stent thrombosis 57 astrocytomas 57 urinary tract symptoms LUTS 57 bivariate analyzes 57 apolipoprotein E4 57 ng ml 57 salivary cortisol 57 IGFBP 3 57 #ng/ml 57 colorectal polyp 57 precancerous cervical 57 invasive ductal 57 IL#B 57 DQB1 * 57 aminotransferase ALT 57 HBeAg 57 nonfatal MI 57 creatinine levels 57 Charlson comorbidity index 57 silent ischemia 57 hypercholesterolaemia 57 Hypertensive 57 Caucasians 57 underwent liver transplantation 57 triglycerides ≥ 57 neurocognitive function 57 mmol liter 57 deep venous thromboses 57 SSc 57 FeNO 57 KRAS mutations occur 57 truncal 57 MBq 57 renal artery stenosis 57 mEq L 57 haplotypes 57 sulphonylureas 57 creatinine clearance 57 #.#mmHg 57 oxycodone CR 57 neoplasias 57 serum TSH 57 chorioamnionitis 57 airway hyper responsiveness 57 mCRPC 57 AAT deficiency 57 Sprague Dawley rats 57 obstructive CAD 57 receiving antiretroviral therapy 57 A1Cs 57 psoriatic arthritis PsA 57 subtrochanteric 57 elevated IOP 57 anovulatory 57 μg g 57 menarche 57 microangiopathy 57 lopinavir r arm 57 missense mutations 57 apolipoprotein E 57 coronary stenosis 57 VaD 57 nodal metastases 57 low ptau levels 57 gastric carcinoma 57 hereditary predisposition 57 malignant neoplasm 57 capillary density 57 hormone receptor negative 57 normal ULN 57 μg ml 57 arteriolar 57 5 hydroxytryptamine 57 androgen excess 57 tipranavir r 57 arterial stiffening 57 MYH9 57 invasive lobular 57 BRCA2 mutation carriers 57 flow mediated dilation 57 neurodevelopmental outcomes 57 parasitaemia 57 GPC5 56 lipid lowering medications 56 A1C levels 56 symptomatic BPH 56 prolactin levels 56 insulin resistance syndrome 56 receiving VICTRELIS 56 preserved LVEF 56 elevated LDH 56 synovial fibroblasts 56 mcg albinterferon alfa 2b 56 nephrolithiasis 56 hamartomas 56 nonsignificant difference 56 hematological parameters 56 faulty BRCA2 gene 56 lipid lowering agents 56 Prostate Lung Colorectal 56 MMSE score 56 underwent surgical resection 56 seroconverted 56 CIN2 + 56 mRNA expression 56 metabolic dysfunction 56 dorsal root ganglion 56 ml kg 56 parkinsonism 56 genotype 56 untreated celiac disease 56 mU liter 56 urinary excretion 56 retrospectively analyzed 56 APOE genotype 56 p = .# [001] 56 hepatitis C genotype 56 prostate cancer PCa 56 systemic lupus erythematosus SLE 56 Endothelial function 56 HMG CoA reductase inhibitory 56 timepoints 56 postoperative AF 56 univariate analyzes 56 2 diabetes T2D 56 thyroid carcinoma 56 leukocyte counts 56 mdx mice 56 Coronary artery calcification 56 triiodothyronine 56 mutated K ras 56 Arch Intern Med 56 receptor blocker 56 GRK5 56 TCF#L# 56 femoral neck fracture 56 carbohydrate intolerance 56 microscopic colitis 56 OSAHS 56 bowel polyps 56 Multicenter AIDS 56 multiple logistic regression 56 artery calcification 56 impaired endothelial 56 Multi Ethnic Study 56 adrenalectomy 56 rheumatoid factor 56 inflammatory biomarkers 56 CI -#.# 56 mg dl 56 postnatally 56 pulmonary arterial 56 serum phosphate levels 56 QTcF 56 recessive inheritance 56 BRCA mutation carriers 56 PsA 56 multivariable analysis 56 daily subcutaneous injections 56 homozygote 56 Sjögren syndrome 56 dehydroepiandrosterone sulfate 56 unfavorable genotypes 56 noninfected 56 CIN3 56 CYP#C# [001] 56 seroprevalence 56 lymphatic cancers 56 abnormal glucose metabolism 56 plasma lipid 56 creatine kinase 56 foveal thickness 56 PON1 56 magnesium intake 56 echocardiographic parameters 56 colonic polyps 56 ventricular myocardium 56 APOE gene 56 EDSS scores 56 APOE4 56 LV ejection fraction 56 milliliters mL 56 congenital deficiency 56 adjunctive placebo 56 grade cervical intraepithelial 56 disease NAFLD 56 chronic hepatitis cirrhosis 56 variant allele 56 monozygotic twins 56 linoleic acid LA 56 underwent resection 56 TAXUS Express Stent 56 progressive PsA 56 myocardial infarctions MIs 56 antibody titer 56 ng mL 56 alkaline phosphatase 56 body fatness 56 Uterine cancer 56 chromosome #p# [001] 56 transaminase levels 56 adjuvant tamoxifen 56 epithelial ovarian cancer 56 Homocysteine levels 56 male Wistar rats 56 leptin deficient mice 56 serum glucose 56 chronic prostatitis 56 SGOT 56 chronic periodontitis 56 susceptibility loci 56 Schizophrenia affects 56 hemoglobin A1C 56 LDL cholesterol levels 56 NYHA class 56 pathologic fractures 56 poorer prognosis 56 benazepril 56 gastric cardia 56 congenital toxoplasmosis 56 homozygous 56 breast carcinoma 56 Ishak fibrosis score 56 salivary cotinine 56 homocysteine concentrations 56 GG genotype 56 nodal metastasis 56 HLA DR4 56 KCNH2 56 enamel defects 56 hypercoagulable 56 myeloperoxidase 56 juvenile idiopathic arthritis 56 brain infarcts 56 myeloproliferative neoplasms 56 cardiomyopathies 56 Myelodysplastic syndromes MDS 56 venlafaxine XR 56 CK # plasma concentrations 56 severe hypoglycaemia 56 PBMCs 56 non aspirin NSAIDs 56 autoimmune thyroiditis 56 octreotide LAR 56 fasting plasma glucose FPG 56 dyslipidemic 56 carotid intima media 56 leiomyomas 56 ALT elevations 56 dizygotic 56 trabecular bone 56 obesity insulin resistance 56 nondrinkers 56 ovarian carcinoma 56 leukocytosis 56 leukaemias 56 hypertensive patients 56 plasma glucose 56 IgA deficiency 56 Complications Trial 56 dietary folate intake 56 elevated troponin 56 metformin monotherapy 56 Multiethnic Study 56 indexes BMIs 56 Nonalcoholic Fatty Liver Disease 56 circulating endothelial cells 56 comorbidities

Back to home page